7Bridge金融集团在Eli Lilly公司最近股票下跌的情况下,将其在Eli Lilly的股份削减了6.1%。 SevenBridge Financial Group cut its shares in Eli Lilly by 6.1%, amid the company's recent stock decline.

7Bridge金融集团有限公司将其在Eli Lilly和Company的股份减少了6.1%,出售了303个股票,现在拥有4 673个股票,价值360万美元。 SevenBridge Financial Group LLC reduced its holdings in Eli Lilly and Company by 6.1%, selling 303 shares and now owning 4,673 shares valued at $3.6 million. Eli Lilly的股票以803.70美元开放,市场上限为7 620亿美元。 Eli Lilly's stock opened at $803.70, with a market cap of $762 billion. 尽管最近股票价格下跌了15.7%,分析家预计该公司本年度的每股收入将达23.48美元。 Despite a recent 15.7% drop in stock price, analysts expect the company to post $23.48 in earnings per share for the year. Elily的重点是糖尿病和肥胖症的药品。 Eli Lilly focuses on pharmaceuticals for diabetes and obesity.